Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction

Ben M. Tsai, Ketan Patel, Meijing Wang, Eric D. Morrell, Paul R. Crisostomo, Daniel R. Meldrum

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Hypoxic pulmonary vasoconstriction may be an adaptive response to shunt blood to well-oxygenated areas of the lung, but hypoxia-induced inflammatory cytokine production leads to acute lung injury. We have previously shown that protein kinase C (PKC) mediates both hypoxic pulmonary vasoconstriction and inflammatory cytokine expression from the pulmonary artery; however, the effect of specific PKC isoform inhibition is currently unknown. We hypothesized that inhibition of classical PKC (cPKC) isoforms would attenuate hypoxic pulmonary vasoconstriction and downregulate hypoxia-induced pulmonary artery cytokine expression. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 6 per group) during hypoxia (95% N2/5% CO2) in the presence of the nonspecific PKC inhibitor bisindolylmaleimide (1 μmol/L), the cPKC inhibitor Gö 6976 (1 - 10 μmol/L), or vehicle (dimethyl sulfoxide, 0.001%). After 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor (TNF) α and interleukin (IL) 1β messenger RNA via reverse transcriptase-polymerase chain reaction. Nonspecific PKC inhibition (bisindolylmaleimide) significantly attenuated hypoxic pulmonary vasoconstriction (44.59 ± 10.52% vs. 87.06 ± 10.91% vehicle; P < 0.001) and downregulated hypoxia-induced expression of pulmonary artery TNF-α. Specific cPKC inhibition (Gö 6976) attenuated pulmonary artery TNF-α expression but had no effect on hypoxic pulmonary vasoconstriction. These data are indicative of the following: (1) nonspecific PKC inhibition attenuates both hypoxic pulmonary vasoconstriction and pulmonary artery TNF-α expression, (2) cPKC inhibition downregulates hypoxia-induced pulmonary artery TNF-α expression but has no effect on hypoxic pulmonary vasoconstriction, and (3) hypoxic pulmonary vasoconstriction and hypoxia-induced pulmonary artery cytokine expression are independent processes.

Original languageEnglish
Pages (from-to)36-39
Number of pages4
JournalShock
Volume27
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Vasoconstriction
Protein Kinase C
Pulmonary Artery
Cytokines
Lung
Tumor Necrosis Factor-alpha
Down-Regulation
Protein Isoforms
Protein C Inhibitor
Acute Lung Injury
Protein Kinase Inhibitors
Dimethyl Sulfoxide
Hypoxia
Reverse Transcriptase Polymerase Chain Reaction
Interleukin-1
Messenger RNA

Keywords

  • Hypoxia
  • Inflammation
  • Pulmonary hypertension
  • Signal transduction

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Physiology

Cite this

Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction. / Tsai, Ben M.; Patel, Ketan; Wang, Meijing; Morrell, Eric D.; Crisostomo, Paul R.; Meldrum, Daniel R.

In: Shock, Vol. 27, No. 1, 01.2007, p. 36-39.

Research output: Contribution to journalArticle

Tsai, Ben M. ; Patel, Ketan ; Wang, Meijing ; Morrell, Eric D. ; Crisostomo, Paul R. ; Meldrum, Daniel R. / Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction. In: Shock. 2007 ; Vol. 27, No. 1. pp. 36-39.
@article{3bd894acfdba4020abfa396ae3b1bc5f,
title = "Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction",
abstract = "Hypoxic pulmonary vasoconstriction may be an adaptive response to shunt blood to well-oxygenated areas of the lung, but hypoxia-induced inflammatory cytokine production leads to acute lung injury. We have previously shown that protein kinase C (PKC) mediates both hypoxic pulmonary vasoconstriction and inflammatory cytokine expression from the pulmonary artery; however, the effect of specific PKC isoform inhibition is currently unknown. We hypothesized that inhibition of classical PKC (cPKC) isoforms would attenuate hypoxic pulmonary vasoconstriction and downregulate hypoxia-induced pulmonary artery cytokine expression. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 6 per group) during hypoxia (95{\%} N2/5{\%} CO2) in the presence of the nonspecific PKC inhibitor bisindolylmaleimide (1 μmol/L), the cPKC inhibitor G{\"o} 6976 (1 - 10 μmol/L), or vehicle (dimethyl sulfoxide, 0.001{\%}). After 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor (TNF) α and interleukin (IL) 1β messenger RNA via reverse transcriptase-polymerase chain reaction. Nonspecific PKC inhibition (bisindolylmaleimide) significantly attenuated hypoxic pulmonary vasoconstriction (44.59 ± 10.52{\%} vs. 87.06 ± 10.91{\%} vehicle; P < 0.001) and downregulated hypoxia-induced expression of pulmonary artery TNF-α. Specific cPKC inhibition (G{\"o} 6976) attenuated pulmonary artery TNF-α expression but had no effect on hypoxic pulmonary vasoconstriction. These data are indicative of the following: (1) nonspecific PKC inhibition attenuates both hypoxic pulmonary vasoconstriction and pulmonary artery TNF-α expression, (2) cPKC inhibition downregulates hypoxia-induced pulmonary artery TNF-α expression but has no effect on hypoxic pulmonary vasoconstriction, and (3) hypoxic pulmonary vasoconstriction and hypoxia-induced pulmonary artery cytokine expression are independent processes.",
keywords = "Hypoxia, Inflammation, Pulmonary hypertension, Signal transduction",
author = "Tsai, {Ben M.} and Ketan Patel and Meijing Wang and Morrell, {Eric D.} and Crisostomo, {Paul R.} and Meldrum, {Daniel R.}",
year = "2007",
month = "1",
doi = "10.1097/01.shk.0000235128.97610.b2",
language = "English",
volume = "27",
pages = "36--39",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Selective protein kinase C inhibition attenuates pulmonary artery cytokine expression without affecting hypoxic pulmonary vasoconstriction

AU - Tsai, Ben M.

AU - Patel, Ketan

AU - Wang, Meijing

AU - Morrell, Eric D.

AU - Crisostomo, Paul R.

AU - Meldrum, Daniel R.

PY - 2007/1

Y1 - 2007/1

N2 - Hypoxic pulmonary vasoconstriction may be an adaptive response to shunt blood to well-oxygenated areas of the lung, but hypoxia-induced inflammatory cytokine production leads to acute lung injury. We have previously shown that protein kinase C (PKC) mediates both hypoxic pulmonary vasoconstriction and inflammatory cytokine expression from the pulmonary artery; however, the effect of specific PKC isoform inhibition is currently unknown. We hypothesized that inhibition of classical PKC (cPKC) isoforms would attenuate hypoxic pulmonary vasoconstriction and downregulate hypoxia-induced pulmonary artery cytokine expression. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 6 per group) during hypoxia (95% N2/5% CO2) in the presence of the nonspecific PKC inhibitor bisindolylmaleimide (1 μmol/L), the cPKC inhibitor Gö 6976 (1 - 10 μmol/L), or vehicle (dimethyl sulfoxide, 0.001%). After 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor (TNF) α and interleukin (IL) 1β messenger RNA via reverse transcriptase-polymerase chain reaction. Nonspecific PKC inhibition (bisindolylmaleimide) significantly attenuated hypoxic pulmonary vasoconstriction (44.59 ± 10.52% vs. 87.06 ± 10.91% vehicle; P < 0.001) and downregulated hypoxia-induced expression of pulmonary artery TNF-α. Specific cPKC inhibition (Gö 6976) attenuated pulmonary artery TNF-α expression but had no effect on hypoxic pulmonary vasoconstriction. These data are indicative of the following: (1) nonspecific PKC inhibition attenuates both hypoxic pulmonary vasoconstriction and pulmonary artery TNF-α expression, (2) cPKC inhibition downregulates hypoxia-induced pulmonary artery TNF-α expression but has no effect on hypoxic pulmonary vasoconstriction, and (3) hypoxic pulmonary vasoconstriction and hypoxia-induced pulmonary artery cytokine expression are independent processes.

AB - Hypoxic pulmonary vasoconstriction may be an adaptive response to shunt blood to well-oxygenated areas of the lung, but hypoxia-induced inflammatory cytokine production leads to acute lung injury. We have previously shown that protein kinase C (PKC) mediates both hypoxic pulmonary vasoconstriction and inflammatory cytokine expression from the pulmonary artery; however, the effect of specific PKC isoform inhibition is currently unknown. We hypothesized that inhibition of classical PKC (cPKC) isoforms would attenuate hypoxic pulmonary vasoconstriction and downregulate hypoxia-induced pulmonary artery cytokine expression. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 6 per group) during hypoxia (95% N2/5% CO2) in the presence of the nonspecific PKC inhibitor bisindolylmaleimide (1 μmol/L), the cPKC inhibitor Gö 6976 (1 - 10 μmol/L), or vehicle (dimethyl sulfoxide, 0.001%). After 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor (TNF) α and interleukin (IL) 1β messenger RNA via reverse transcriptase-polymerase chain reaction. Nonspecific PKC inhibition (bisindolylmaleimide) significantly attenuated hypoxic pulmonary vasoconstriction (44.59 ± 10.52% vs. 87.06 ± 10.91% vehicle; P < 0.001) and downregulated hypoxia-induced expression of pulmonary artery TNF-α. Specific cPKC inhibition (Gö 6976) attenuated pulmonary artery TNF-α expression but had no effect on hypoxic pulmonary vasoconstriction. These data are indicative of the following: (1) nonspecific PKC inhibition attenuates both hypoxic pulmonary vasoconstriction and pulmonary artery TNF-α expression, (2) cPKC inhibition downregulates hypoxia-induced pulmonary artery TNF-α expression but has no effect on hypoxic pulmonary vasoconstriction, and (3) hypoxic pulmonary vasoconstriction and hypoxia-induced pulmonary artery cytokine expression are independent processes.

KW - Hypoxia

KW - Inflammation

KW - Pulmonary hypertension

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=33845716176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845716176&partnerID=8YFLogxK

U2 - 10.1097/01.shk.0000235128.97610.b2

DO - 10.1097/01.shk.0000235128.97610.b2

M3 - Article

VL - 27

SP - 36

EP - 39

JO - Shock

JF - Shock

SN - 1073-2322

IS - 1

ER -